Your browser doesn't support javascript.
loading
Why classical receptor theory, which ignores allostery, can effectively measure the strength of an allosteric effect as agonist's efficacy.
Onaran, H Ongun; Costa, Tommaso.
Afiliación
  • Onaran HO; Department of Pharmacology, Faculty of Medicine, Ankara University, Ankara, Turkey.
  • Costa T; Istituto Superiore di Sanità (retired), Viale America 111, Rome, Italy.
Br J Pharmacol ; 181(12): 1757-1767, 2024 Jun.
Article en En | MEDLINE | ID: mdl-38343142
ABSTRACT
BACKGROUND AND

PURPOSE:

The classical theory of receptor action has been used for decades as a powerful tool to estimate molecular determinants of ligand-induced receptor activation (i.e., affinity and efficacy) from experimentally observable biological responses. However, it is also a well-recognized fact that the receptor-binding and activation mechanisms, and the parameters thereof, described in the classical theory contradict with the modern view of receptor activation based on allosteric principles. EXPERIMENTAL

APPROACH:

We used mathematical analysis, along with some numerical simulations, to answer the key question as to what extent the classical theory is compatible-if at all-with the modern understanding of receptor activation. KEY

RESULTS:

Here, we showed conclusively that (1) receptor activation equations based on allosteric principles contain the logic of the classical theory in disguise, and therefore, (2) estimates of "intrinsic efficacy" (ε) obtained by means of classical techniques (i.e., null methods or fitting the operational model to concentration-response data) are equivalent to the allosteric coupling factors that represent the molecular efficacy of ligands. CONCLUSION AND IMPLICATIONS Thus, we conclude that despite the justified criticisms it has received so far, the classical theory may continue to be useful in estimating ligand efficacy from experimental data, if used properly. Here, we also provide rigorous criteria for the proper use of the theory. These findings not only have implications for ligand classification but also resolve some long lasting discussions in the field of bias agonism in GPCR, which requires reasonable estimates of relative ligand efficacies at different signalling pathways.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Modelos Biológicos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Br J Pharmacol Año: 2024 Tipo del documento: Article País de afiliación: Turquía

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Modelos Biológicos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Br J Pharmacol Año: 2024 Tipo del documento: Article País de afiliación: Turquía